Morgan Stanley maintains Underweight on MGM Resorts stock amid takeover bid

MGM Resorts is trading around $50.42 after People Inc. disclosed a plan to buy the remaining 74% of the company at $48.30 per share, implying a roughly 10% premium to Friday’s close and a potential take-private valuation near 7.7x 2026 EV/EBITDAR. Morgan Stanley reiterated an Underweight rating and $35 price target, while MGM’s Q1 2026 results were mixed: EPS of $0.49 missed the $0.56 estimate by 12.5%, but revenue of $4.45 billion beat the $4.36 billion consensus by 2.06%. The board is reviewing the proposal, and the stock has gained 14% over the past week.

Analysis

The key market signal is not the headline bid, but the re-rating of MGM from a sleepy asset story into a real control-premium situation with an awkward free-float overhang. Once a 26% insider/strategic holder is effectively a sponsor, the probability distribution shifts toward a transaction or a much tighter trading band, which can compress the usual discount to reported EV/EBITDAR multiples faster than fundamentals alone would justify. That said, the current print already embeds meaningful deal optionality, so incremental upside from here likely depends on either a superior competing bidder or a materially higher bid, not simply “deal optimism.”

The second-order winner is Caesars. A successful MGM takeout would validate the private-markets playbook for casino assets and likely reinforce the scarcity value of scaled domestic gaming exposure, which is why the Fertitta/CZR transaction matters beyond its own perimeter. In practice, that can lift the relative valuation floor for CZR and pressure public peers to articulate capital-return or asset-sale paths, but it also narrows the pool of obvious public longs because the easiest catalyst is now M&A, not operating acceleration.

The biggest risk is timing: deal probability can remain high while IRR collapses if the spread to the offer price gets competed away too slowly. Over days, the stock can stay pinned near the bid; over months, downside reopens if financing, regulatory scrutiny, or board resistance stalls the process and the market reverts to a lower-quality cash-flow multiple. The contrarian view is that the street may be overestimating how cleanly a 74% buyout gets done at the indicated price when the equity is already trading above it; that usually signals either a better offer is needed or the market is sniffing a higher strategic value than the bidder is acknowledging.

Key Decisions for Investors

• Short MGM against the offer spread only if you can source cheap borrow and express it as a tight event-risk trade; target a quick 5-8% capture of mean reversion if the stock fades back toward the indicated price, but use a hard stop on any credible topping-bid headlines.
• Long CZR on a 1-3 month horizon as a relative-value beneficiary of renewed casino M&A interest; upside is that takeover comps and sector scarcity support multiple expansion, while risk is that MGM deal skepticism bleeds into the whole group and compresses sentiment.
• For option-sensitive accounts, buy MGM downside puts or put spreads into any sharp post-news strength; the best risk/reward is if implied vol stays elevated while the stock trades above the proposal, because a stalled process can reprice the name quickly back into the low-40s/upper-30s range.
• Avoid chasing MGM common above the bid unless a topping bidder emerges; the asymmetry is poor because near-term upside is capped by deal mechanics, while any financing or governance snag can erase several dollars per share rapidly.
• If you want event exposure without single-name deal risk, prefer a basket long in CZR/MSGS-style gaming assets versus short lower-quality discretionary names; the thesis is that capital markets will reward scarce, controllable cash-flow assets while punishing undifferentiated operators.